HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

FHCRC selects SciQuest to enhance its ERP system and improve on cost-efficiency

Fred Hutchinson Cancer Research Center, a world-renowned research and treatment institution in Seattle, has selected SciQuest, Inc., a leading provider of on-demand strategic procurement and supplier enablement solutions, to enhance its enterprise resource planning system and improve on cost-efficiency.

25 Jun 2010

MDG targets still attainable despite setbacks from global economic situation, U.N. report says

Efforts to curb poverty worldwide have been slowed by the global economic situation, but the developing world is still on track to reach the Millennium Development Goal (MDG) of halving the number of people living on less than $1 per day by 2015 - according to an annual U.N. report (.pdf) on the MDGs, which this year shows a "mixed picture" on reaching all eight targets - the Associated Press reports (Lederer, 6/23).

25 Jun 2010

Merck proposes to initiate Phase II proof-of-concept clinical study of posaconazole for chronic Chagas disease

Merck today announced plans to initiate a Phase II investigational proof-of-concept clinical study to evaluate its oral antifungal agent posaconazole for the treatment of chronic Chagas disease. Chagas disease results from infection with the parasite Trypanosoma cruzi that is spread by biting insects. The disease is estimated to affect approximately eight million people in Latin America, of whom approximately 30-40 percent will develop serious cardiac disease, digestive disease, or both as a result of this infection.

24 Jun 2010

Physician-in-chief at Texas Children's Hospital honored with Jacqueline Kennedy Onassis Award

Last night at the 38th annual Jefferson Awards, Mark W. Kline, M.D., physician-in-chief at Texas Children's Hospital in Houston and chair of pediatrics at Baylor College of Medicine, was honored with the Jacqueline Kennedy Onassis Award for "Outstanding Community Service Benefiting Local Communities" for his dedication to treating children affected by HIV/AIDS around the world

24 Jun 2010

ABL to host CRP-Santé COMET subtyping tool within TherapyEdge servers

The licensing and distribution agreement allows ABL to directly host COMET (COntext-based Modeling for Expeditious Typing) subtyping tool developed at CRP-Santé within the TherapyEdge servers; it will mainly interact with the ViroScore Suite system to characterize HIV-1 virus subtypes.

24 Jun 2010

Risk, incidence of VTE differs between races

A new study of 1,960 White-Americans and 368 Black-Americans with objectively diagnosed venous thromboembolism (VTE) showed that, compared to Whites, Blacks had a significantly higher proportion with pulmonary embolism (PE), including idiopathic PE among Black women, and a significantly higher proportion of Blacks with VTE were women (71% vs 61% for Whites) The study is published today in the American Journal of Hematology.

24 Jun 2010

June issue of Clinic Women's HealthSource provides overview of anemia

Anemia is not a normal part of aging, yet it's fairly common in older adults and causes frailness, weakness and increased risk of falls. According to Mayo Clinic Women's HealthSource, more than one in 10 older adults has anemia. Twenty percent of women are anemic by age 85.

24 Jun 2010

G8 Summit needs to focus on MDGs to address AIDS crisis: IAS

In 2005 the international community made an historic commitment to achieve universal access to HIV prevention, treatment and care by 2010 at the Group of Eight (G8) summit in Gleneagles, Scotland. Despite important progress, the world is not yet on track to achieve this commitment, and there are troubling signs that donors and implementing countries are capping or shrinking funding for the HIV response.

24 Jun 2010

NIH to invest $25M over five years for international collaboration on genetic research in Africa

The NIH on Tuesday announced a partnership with Wellcome Trust and the African Society for Human Genetics that will enable African researchers to "use the latest genetic and clinical technology to study common health problems, such as cardiovascular disease, cancer and other diseases," VOA News reports (DeCapua, 6/22).

24 Jun 2010

Mixed progress on MDGs, additional advancement still possible, report says

Poverty rates in 10 African countries have been halved over the last two decades, while child mortality rates have gone up in six sub-Saharan African countries, according to a report (.pdf) from the Overseas Development Institute (ODI) and the U.N. Millennium Campaign, which emphasized that progress towards the Millennium Development Goals (MDGs) is possible, the Associated Press/St. Petersburg Times reports (Straziuso, 6/22).

24 Jun 2010

Miller-McCune examines debate over redistribution of some foreign aid funds from HIV/AIDS to other diseases

Through the lens of health conditions faced by people in Mbarara, Uganda, Miller-McCune examines the debate over redistributing some foreign aid funds from HIV/AIDS to fight other diseases.

24 Jun 2010

CPRIT grants $3.7M to Rice University researchers to fund cancer diagnostics program

The Cancer Prevention and Research Institute of Texas has granted $3.7 million to Rice University researchers to fund an innovative cancer diagnostics program.

24 Jun 2010

World Bank provides over $63M for multi-country lab network in East Africa region

East African Business Week/allAfrica.com reports on the recent decision by the World Bank to back the creation of "a unique regional network of 25 public health laboratories" in Kenya, Tanzania, Uganda and Rwanda with $63.66 million in support.

23 Jun 2010

European drugmakers lead in making medicines available to developing world, Index says

European drug companies came out ahead of their U.S. counterparts in making medicines available to people in developing countries, but their lead is beginning to shrink, according to the Access to Medicines Index, released on Monday, Reuters reports (Kelland, 6/21).

23 Jun 2010

Opinions: Canada's role in global health; Drug licensing agreements promote drug access; Funding for USAID, state; Haiti

After outlining the work of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Michel Kazatchkine, the organization's executive director, highlights the role Canada can play in determining "whether the world can overcome AIDS, tuberculosis and malaria" in a Toronto Star opinion piece, noting the upcoming G8 and G20 summits, as well as the Millennium Development Goal meeting later this year.

23 Jun 2010

Understanding HIV viral protein structure could lead to new molecular medicines: Study

The UK's National Physical Laboratory is involved in a collaborative project that is helping to further the understanding of HIV viral protein structure which could lead to new molecular medicines.

23 Jun 2010

Media examine GHI, U.S. HIV/AIDS funding

PBS' NewsHour's "The Rundown" blog examines the recent naming of eight countries to receive additional technical and management resources under President Barack Obama's Global Health Initiative (GHI).

23 Jun 2010

TheraQuest launches new analgesic product pipeline

TheraQuest Biosciences, Inc., a clinical stage pain management company today unveiled its analgesic product pipeline. TheraQuest also announced the launch of its new corporate website at http://www.theraquestinc.com.

23 Jun 2010

Mobile, supervised drug use units considered cost effective: Report

Drug abuse experts believe Melbourne needs a mobile, supervised drug injecting van. This is mainly due to the geographical spread of drug abusers in the region.

22 Jun 2010

SynCon DNA vaccine shows advantages in magnitude and breadth of immune responses in non-human primates

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.

22 Jun 2010

HIV/AIDS News and Research

Further Reading

FHCRC selects SciQuest to enhance its ERP system and improve on cost-efficiency

MDG targets still attainable despite setbacks from global economic situation, U.N. report says

Merck proposes to initiate Phase II proof-of-concept clinical study of posaconazole for chronic Chagas disease

Physician-in-chief at Texas Children's Hospital honored with Jacqueline Kennedy Onassis Award

ABL to host CRP-Santé COMET subtyping tool within TherapyEdge servers

Risk, incidence of VTE differs between races

June issue of Clinic Women's HealthSource provides overview of anemia

G8 Summit needs to focus on MDGs to address AIDS crisis: IAS

NIH to invest $25M over five years for international collaboration on genetic research in Africa

Mixed progress on MDGs, additional advancement still possible, report says

Miller-McCune examines debate over redistribution of some foreign aid funds from HIV/AIDS to other diseases

CPRIT grants $3.7M to Rice University researchers to fund cancer diagnostics program

World Bank provides over $63M for multi-country lab network in East Africa region

European drugmakers lead in making medicines available to developing world, Index says

Opinions: Canada's role in global health; Drug licensing agreements promote drug access; Funding for USAID, state; Haiti

Understanding HIV viral protein structure could lead to new molecular medicines: Study

Media examine GHI, U.S. HIV/AIDS funding

TheraQuest launches new analgesic product pipeline

Mobile, supervised drug use units considered cost effective: Report

SynCon DNA vaccine shows advantages in magnitude and breadth of immune responses in non-human primates

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News